CogstateCOGZF 90 Interest Coverage is 361.90 as of Dec. 2025, which is 739% above its 10-year median of 43.16. GuruFocus rates COGZF with a GF Score™ of 90/100 and a GF Value™ of $1.58 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 453 Healthcare Providers & Services companies, Cogstate ranks better than 87.86% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Cogstate's
Operating Income
for the
six
months ended in Dec. 2025 was $3.62 Mil. Cogstate's Interest Expense for the
six
months ended in Dec. 2025 was $-0.01 Mil.
Cogstate's interest coverage for the quarter that ended in Dec. 2025 was 361.90.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Cogstate Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Cogstate's Interest Coverage or its related term are showing as below:
COGZF'
s Interest Coverage Range Over the Past 10 Years
Min: 2.46 Med: 43.16 Max: 222.57
Current: 222.57
COGZF's Interest Coverage is ranked better than 87.86% of 453
companies
in the Healthcare Providers & Services industry
Industry Median: 7.98
vs COGZF: 222.57
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Cogstate Interest Coverage Related Terms
Cogstate Interest Coverage Historical Data
* Premium members only.
The historical data trend for Cogstate's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
COGZF vs VEEV, BTSG, TEM: Interest Coverage Comparison
For the Health Information Services subindustry, Cogstate's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cogstate Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Cogstate's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cogstate (COGZF) has a Interest Coverage of 361.90 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Cogstate and its competitors. This is 739% above median its historical median of 43.16. Over the past decade, Cogstate's Interest Coverage has ranged from 2.46 to 222.57. According to the industry distribution chart, Cogstate ranks #55 out of 453 companies in the Healthcare Providers & Services industry, placing it in the top 12.1%.
Is Cogstate's Interest Coverage too high?
Cogstate's current Interest Coverage of 361.90 is 739% above median its 10-year median of 43.16. Over the past 10 years, this metric has ranged from a low of 2.46 to a high of 222.57. The Healthcare Providers & Services industry median Interest Coverage is 7.98. Cogstate's value of 361.90 is 4435.1% above this industry median. Based on the distribution chart, Cogstate ranks #55 out of 453 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Cogstate has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cogstate's Interest Coverage compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cogstate ranks #55 out of 453 companies for Interest Coverage. This places Cogstate in the top 12% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 7.98. Cogstate's value of 361.90 is 4435.1% above this benchmark. Historically, Cogstate's own Interest Coverage has ranged from 2.46 to 222.57 over the past decade. While the company's 10-year median is 43.16 vs. the industry median of 7.98, Cogstate has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.98, based on 453 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cogstate's current Interest Coverage of 361.90 is 4435.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Cogstate and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cogstate's current Interest Coverage is 361.90, which is 739% above median its own 10-year median of 43.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogstate stock overvalued right now?
Based on GuruFocus' analysis, Cogstate (COGZF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.58, compared to a current price of $1.89 — trading 19.6% above its estimated fair value. The current Interest Coverage is 361.90, which is 739% above median its 10-year median of 43.16 and 4435.1% above the Healthcare Providers & Services industry median of 7.98. Cogstate's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Cogstate (COGZF), the current Interest Coverage is 361.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cogstate (COGZF) Overvalued in 2026?
Based on GuruFocus' analysis, Cogstate stock appears to be overvalued.
The current stock price of $1.89 is trading 19.6% above its estimated GF Value™ of $1.58.
GuruFocus considers Cogstate to be Modestly Overvalued.
Key valuation signals for COGZF:
Interest Coverage: 361.90 (739% above median its 10-year median of 43.16)
GF Value™: $1.58 vs. price of $1.89 (19.6% above fair value)
Industry Position: 4435.1% above the Healthcare Providers & Services median (#55 of 453)
No single metric tells the full story. See the COGZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
90GF Score
Get the complete analysis for COGZF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COGZF has been successfully added to your 
